PURPOSE: Rheumatoid arthritis (RA) involves migration of macrophages into inflamed areas. (R)-[(11)C]PK11195 binds to peripheral benzodiazepine receptors, expressed on macrophages, and may be used to quantify inflammation using positron emission tomography (PET). This study evaluated methods for the quantification of (R)-[(11)C]PK11195 binding in the knee joints of RA patients. METHODS: Data from six patients with RA were analysed. Dynamic PET scans were acquired in 3-D mode following (R)-[(11)C]PK11195 injection. During scanning arterial radioactivity concentrations were measured to determine the plasma (R)-[(11)C]PK11195 concentrations. Data were analysed using irreversible and reversible one-tissue and two-tissue compartment models and input functions with various types of metabolite correction. Model preferences according to the Akaike information criterion (AIC) and correlations between measures were evaluated. Correlations between distribution volume (V(d)) and standardized uptake values (SUV) were evaluated. RESULTS: AIC indicated optimal performance for a one-tissue reversible compartment model including blood volume. High correlations were observed between V(d) obtained using different input functions (R(2)=0.80-1.00) and between V(d) obtained with one- and two-tissue reversible compartment models (R(2)=0.75-0.94). A high correlation was observed between optimal V(d) and SUV after injection (R(2)=0.73). CONCLUSION: (R)-[(11)C]PK11195 kinetics in the knee were best described by a reversible single-tissue compartment model including blood volume. Applying metabolite corrections did not increase sensitivity. Due to the high correlation with V(d), SUV is a practical alternative for clinical use.
PURPOSE:Rheumatoid arthritis (RA) involves migration of macrophages into inflamed areas. (R)-[(11)C]PK11195 binds to peripheral benzodiazepine receptors, expressed on macrophages, and may be used to quantify inflammation using positron emission tomography (PET). This study evaluated methods for the quantification of (R)-[(11)C]PK11195 binding in the knee joints of RApatients. METHODS: Data from six patients with RA were analysed. Dynamic PET scans were acquired in 3-D mode following (R)-[(11)C]PK11195 injection. During scanning arterial radioactivity concentrations were measured to determine the plasma (R)-[(11)C]PK11195 concentrations. Data were analysed using irreversible and reversible one-tissue and two-tissue compartment models and input functions with various types of metabolite correction. Model preferences according to the Akaike information criterion (AIC) and correlations between measures were evaluated. Correlations between distribution volume (V(d)) and standardized uptake values (SUV) were evaluated. RESULTS: AIC indicated optimal performance for a one-tissue reversible compartment model including blood volume. High correlations were observed between V(d) obtained using different input functions (R(2)=0.80-1.00) and between V(d) obtained with one- and two-tissue reversible compartment models (R(2)=0.75-0.94). A high correlation was observed between optimal V(d) and SUV after injection (R(2)=0.73). CONCLUSION: (R)-[(11)C]PK11195 kinetics in the knee were best described by a reversible single-tissue compartment model including blood volume. Applying metabolite corrections did not increase sensitivity. Due to the high correlation with V(d), SUV is a practical alternative for clinical use.
Authors: Hazel A Jones; Kurt Hamacher; John C Clark; John B Schofield; Thomas Krausz; Christopher Haslett; Alan R Boobis Journal: Toxicol Appl Pharmacol Date: 2005-09-01 Impact factor: 4.219
Authors: J Versijpt; J C Debruyne; K J Van Laere; F De Vos; J Keppens; K Strijckmans; E Achten; G Slegers; R A Dierckx; J Korf; J L De Reuck Journal: Mult Scler Date: 2005-04 Impact factor: 6.312
Authors: Henri N J M Greuter; Patricia L B van Ophemert; Gert Luurtsema; Bart N M van Berckel; Eric J F Franssen; Bert D Windhorst; Adriaan A Lammertsma Journal: Nucl Med Biol Date: 2005-04 Impact factor: 2.408
Authors: Dima A Hammoud; Christopher J Endres; Ankit R Chander; Tomas R Guilarte; Dean F Wong; Ned C Sacktor; Justin C McArthur; Martin G Pomper Journal: J Neurovirol Date: 2005-08 Impact factor: 2.643
Authors: Ji Hyeon Ju; Kwi Young Kang; In Je Kim; Jang Uk Yoon; Hyun-Sook Kim; Sung-Hwan Park; Ho-Youn Kim Journal: Clin Rheumatol Date: 2008-03-28 Impact factor: 2.980
Authors: E H Elzinga; C J van der Laken; E F I Comans; A A Lammertsma; B A C Dijkmans; A E Voskuyl Journal: Mol Imaging Biol Date: 2007 Nov-Dec Impact factor: 3.488
Authors: Filip Gemmel; Hans Van den Wyngaert; Charito Love; M M Welling; Paul Gemmel; Christopher J Palestro Journal: Eur J Nucl Med Mol Imaging Date: 2012-02-24 Impact factor: 9.236
Authors: G Gerasimou; E Moralidis; E Papanastasiou; G Liaros; T Aggelopoulou; E Triantafyllidou; N Lytras; L Settas; A Gotzamani-Psarrakou Journal: Hippokratia Date: 2011-01 Impact factor: 0.471
Authors: Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy Journal: Front Med (Lausanne) Date: 2022-06-06
Authors: Laurent Bitker; François Dhelft; Sophie Lancelot; Didier Le Bars; Nicolas Costes; Nazim Benzerdjeb; Maciej Orkisz; Jean-Christophe Richard Journal: Eur J Nucl Med Mol Imaging Date: 2022-02-07 Impact factor: 10.057
Authors: William C Kreisl; Kimberly J Jenko; Christina S Hines; Chul Hyoung Lyoo; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Thomas Hyde; Joel E Kleinman; Victor W Pike; Francis J McMahon; Robert B Innis Journal: J Cereb Blood Flow Metab Date: 2012-09-12 Impact factor: 6.200
Authors: Yoony Y J Gent; Karin Weijers; Carla F M Molthoff; Albert D Windhorst; Marc C Huisman; Desirée E C Smith; Sumith A Kularatne; Gerrit Jansen; Philip S Low; Adriaan A Lammertsma; Conny J van der Laken Journal: Arthritis Res Ther Date: 2013-03-01 Impact factor: 5.156
Authors: Yoony Y J Gent; Karin Weijers; Carla F M Molthoff; Albert D Windhorst; Marc C Huisman; Michael Kassiou; Gerrit Jansen; Adriaan A Lammertsma; Conny J van der Laken Journal: Arthritis Res Ther Date: 2014-03-14 Impact factor: 5.156